UpHealth, Inc. (NYSE:UPH) Expected to Announce Quarterly Sales of $40.28 Million

Analysts forecast that UpHealth, Inc. (NYSE:UPHGet Rating) will post $40.28 million in sales for the current fiscal quarter, according to Zacks. Two analysts have provided estimates for UpHealth’s earnings. The lowest sales estimate is $33.98 million and the highest is $46.59 million. The firm is scheduled to announce its next quarterly earnings results on Monday, January 1st.

On average, analysts expect that UpHealth will report full year sales of $206.45 million for the current financial year, with estimates ranging from $205.95 million to $206.95 million. For the next fiscal year, analysts forecast that the company will post sales of $260.61 million, with estimates ranging from $258.14 million to $263.09 million. Zacks’ sales calculations are an average based on a survey of sell-side research analysts that cover UpHealth.

Several analysts have weighed in on the stock. Lake Street Capital cut shares of UpHealth from a “buy” rating to a “hold” rating in a research note on Thursday, March 31st. Zacks Investment Research raised shares of UpHealth from a “sell” rating to a “hold” rating in a research note on Tuesday. Finally, Northland Securities decreased their price target on shares of UpHealth from $10.50 to $4.50 and set an “outperform” rating on the stock in a research note on Thursday, March 31st. Two analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and a consensus target price of $9.63.

Shares of UPH traded down $0.02 during trading hours on Thursday, reaching $0.99. 875,700 shares of the company traded hands, compared to its average volume of 847,987. The firm has a fifty day moving average of $2.02. The company has a debt-to-equity ratio of 0.16, a quick ratio of 1.09 and a current ratio of 1.12. UpHealth has a 1-year low of $0.92 and a 1-year high of $10.72.

A number of hedge funds have recently made changes to their positions in the business. Lynrock Lake LP acquired a new stake in UpHealth in the fourth quarter worth $2,837,000. Perkins Capital Management Inc. acquired a new stake in UpHealth in the fourth quarter worth $2,104,000. Renaissance Technologies LLC raised its holdings in UpHealth by 409.5% in the fourth quarter. Renaissance Technologies LLC now owns 784,107 shares of the company’s stock worth $1,756,000 after purchasing an additional 630,207 shares during the period. Omni Event Management Ltd acquired a new stake in UpHealth in the fourth quarter worth $1,681,000. Finally, LMR Partners LLP raised its holdings in UpHealth by 498.9% in the fourth quarter. LMR Partners LLP now owns 700,000 shares of the company’s stock worth $1,568,000 after purchasing an additional 583,118 shares during the period. 6.46% of the stock is currently owned by hedge funds and other institutional investors.

About UpHealth (Get Rating)

UpHealth, Inc operates as a digital health services company. It provides patient-centric digital health platform and tech-enabled services to manage health and integrate care. The company's solutions include Syntranet Core Platform, an integrated care management platform; Global Telemedicine; MedQuest Digital Pharmacy, a full-service pharmacy that offers manufactured medication, custom compounded medications, nutraceuticals, lab testing, advocacy, education, etc.; and Behavioral Telehealth solutions.

Featured Stories

Get a free copy of the Zacks research report on UpHealth (UPH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for UpHealth (NYSE:UPH)

Receive News & Ratings for UpHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UpHealth and related companies with MarketBeat.com's FREE daily email newsletter.